



Mon Jan 26, 2015 1:44am EST
Jan 26 (Reuters) - Ipsen SA :
* Ipsen announces topline results of two double-blind phase III studies of Dysport in lower limb spasticity in children and in adults
* PLL phase III study of Dysport shows statistically significant response versus placebo in improvement of muscle tone
* PLL phase III study of Dysport shows as well statistically significant overall benefit versus placebo, as measured by physician global assessment
* Comprehensive results from double-blind studies on Dysport to be disclosed in next few months at major international congresses
* Study proves Dysport demonstrates high benefit in adults with stroke or traumatic brain injury causing lower limb spasticity - Principal Investigator of all study Source text for Eikon: Further company coverage: (Gdynia Newsroom)